TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
112.08
-1.82 (-1.60%)
At close: Mar 23, 2026, 4:00 PM EDT
113.30
+1.22 (1.09%)
After-hours: Mar 23, 2026, 7:53 PM EDT
TransMedics Group Stock Forecast
Stock Price Forecast
The 9 analysts that cover TransMedics Group stock have a consensus rating of "Buy" and an average price target of $154, which forecasts a 37.40% increase in the stock price over the next year. The lowest target is $130 and the highest is $175.
Price Target: $154 (+37.40%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $115 → $130 | Hold | Maintains | $115 → $130 | +15.99% | Mar 9, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $114 → $149 | Hold | Maintains | $114 → $149 | +32.94% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $175 | Buy | Maintains | $150 → $175 | +56.14% | Feb 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $160 | Buy | Maintains | $140 → $160 | +42.76% | Feb 25, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $155 → $170 | Buy | Maintains | $155 → $170 | +51.68% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
753.92M
from 605.49M
Increased by 24.51%
Revenue Next Year
895.10M
from 753.92M
Increased by 18.73%
EPS This Year
2.61
from 4.87
Decreased by -46.35%
EPS Next Year
3.76
from 2.61
Increased by 43.80%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 786.1M | 966.0M | ||
| Avg | 753.9M | 895.1M | ||
| Low | 714.3M | 836.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 29.8% | 28.1% | ||
| Avg | 24.5% | 18.7% | ||
| Low | 18.0% | 11.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.30 | 4.40 | ||
| Avg | 2.61 | 3.76 | ||
| Low | 1.71 | 2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -32.3% | 68.3% | ||
| Avg | -46.4% | 43.8% | ||
| Low | -65.0% | -6.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.